Cordlife Group Limited (CLIFF)

Market Cap	39.63M
Revenue (ttm)	20.26M
Net Income (ttm)	-13.84M
Shares Out	n/a
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,031
Average Volume	25
Open	0.1717
Previous Close	0.1721
Day's Range	0.1717 - 0.1722
52-Week Range	0.0954 - 0.2984
Beta	0.76
RSI	93.93
Earnings Date	Aug 11, 2025

About Revance Therapeutics

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2001
• Employees: 538
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLIFF